KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,168,000 | +10.1% | 63,700 | -3.5% | 0.02% | +41.7% |
| Q1 2022 | $1,061,000 | -1.5% | 65,980 | +14.7% | 0.01% | +9.1% |
| Q3 2021 | $1,077,000 | -10.9% | 57,500 | -0.9% | 0.01% | -8.3% |
| Q2 2021 | $1,209,000 | -26.3% | 58,000 | 0.0% | 0.01% | -29.4% |
| Q1 2021 | $1,640,000 | -13.4% | 58,000 | 0.0% | 0.02% | -22.7% |
| Q4 2020 | $1,894,000 | +28.8% | 58,000 | +20.8% | 0.02% | +10.0% |
| Q3 2020 | $1,471,000 | +159.0% | 48,000 | -15.9% | 0.02% | +81.8% |
| Q1 2020 | $568,000 | -73.8% | 57,100 | -63.8% | 0.01% | -67.6% |
| Q4 2019 | $2,170,000 | -14.0% | 157,800 | -5.1% | 0.03% | -27.7% |
| Q3 2019 | $2,523,000 | -11.8% | 166,300 | +14.5% | 0.05% | -4.1% |
| Q2 2019 | $2,859,000 | +488.3% | 145,200 | +395.6% | 0.05% | +81.5% |
| Q1 2019 | $486,000 | – | 29,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |